South and Central America ePRO, ePatient Diaries, and eCOA Market
South and Central America ePRO, ePatient Diaries, and eCOA Market is growing at a CAGR of 14.2% to reach US$ 229.0 million by 2028 from US$ 90.3 million in 2021 by Type of Solution, Modality, End User.

Published On: Jun 2021

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South and Central America ePRO, ePatient Diaries, and eCOA Market

e-Clinical Outcome Assessments Segment has the Largest Share of Type of Solution in the South and Central America ePRO, ePatient Diaries, and eCOA Market during 2021–2028

According to a new market research study on “South and Central America ePRO, ePatient Diaries, and eCOA Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type of Solution, Modality, and End User,” is expected to reach US$ 229.0 million by 2028 from US$ 90.3 million in 2021. The market is estimated to grow at a CAGR of 14.2% from 2021 to 2028. The report provides trends prevailing in the South and Central America ePRO, ePatient Diaries, and eCOA market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing demand for electronic health records (EHRs), rising use of smartphones and growing demand for clinical trials are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the concerns regarding data privacy.

The COVID? 19 pandemic is a critical test for the already overburdened and underfunded public healthcare systems of South and Central America. They have responded to the situation by closing borders, ordering quarantines, and imposing a host of restrictions to keep people confined at home. The COVID-19 pandemic presented numerous impacts on health systems, social life, and human behavior. It remains a challenge for local communities. While ePRO methods in clinical trials are not new, the pandemic has accelerated their adoption. As physicians and patients have become more accepting of digital technologies and wearables, more opportunities for remote monitoring have arisen. Drug developers are challenged to rapidly assess the effectiveness of existing vaccines against evolving SARS-CoV-2 strains due to the virus's constant mutations. As a result, increased visibility and oversight of data collection, faster trial implementation, and real-time data sharing are all priorities. These factors had a potential impact on the South and Central America ePRO, e-Patient Diaries, and eCOA market.

The market for ePRO, ePatient Diaries, and eCOA market is segmented into type of solution, modality, and end user. In 2020, the eCOA (Electronic Clinical Outcome Assessments) segment accounted for the South and Central America ePRO, ePatient diaries, and eCOA market's largest market share. This large share can be attributed to the advantages offered by eCOA, as eCOA uses technology such as smartphones, laptops, computers to enable patients, nurses, and doctors to consult directly about medical test results. ECOA provides highly accurate knowledge that better understands and simplifies the acceptance process for patient reviews in clinical trials. In addition, the increasing cost for pharmaceutical manufacturers of modern overall drug development methodologies has led to their use of electronic information collection by way of paper-based processes. Data processing across eCOA networks improves the quality of the information gathered, harmonizes data systems, and gives users valuable benefits, such as data interpretation.

The Diary Pte. Ltd, ICON PLC, PAREXEL INTERNATIONAL CORPORATION, Bracket Global LLC, Dassault Systèmes SE, and CRF Health are among the leading companies in the South and Central America ePRO, ePatient Diaries, and eCOA market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, ERT, announced a powerful new solution for enabling the collection, processing and analysis of photos and audio as part of clinical trial eCOA assessments. This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality, and data security.

The report segments the South and Central America EPRO, ePatient Diaries, and eCOA market as follows:

By Type of Solution

  • eClinical Outcome Assessments
  • e-Patient Reported Outcomes
  • Clinician Reported Outcomes
  • Observer Reported Outcomes
  • Performance Outcomes
  • e-Patient Diaries

By Modality

  • Computer
  • Mobile Devices

By End User

  • Clinical Trial Sponsors
  • Contract Research Organizations
  • Hospitals
  • Academic Institutes
  • Pharmaceutical Companies
  • Others

By Country

  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com